Quantcast

Latest Angina pectoris Stories

2011-11-02 21:50:08

When given for hours as a continuous dose, the heart medication nitroglycerin backfires -- increasing the severity of subsequent heart attacks, according to a study of the compound in rats by researchers at the Stanford University School of Medicine. "Basically it's a cautionary tale," said professor of chemical and systems biology Daria Mochly-Rosen, PhD, senior author of the study that will be published Nov. 2 in Science Translational Medicine. "Here is a practice in medicine used for...

2011-10-25 11:34:10

A Heart and Stroke Foundation study has found that women under age 55 fare worse than their male counterparts following a heart attack — and their health status declines more than that of their male counterparts after one month. The AMI55 study found that women between the ages of 20 and 55 had significantly worse physical limitations, more recurrences of chest pain, and worse quality of life than men one month after a heart attack — and, compared to their baseline scores,...

2011-10-11 18:04:16

Fewer deaths and myocardial infarctions in unstable angina pectoris and NSTEMI / AMNOG procedure has passed the first practical test Since the start of 2011, the active ingredient ticagrelor can be prescribed in Germany in addition to acetylsalicylic acid (ASA) to avoid blood clots in patients with acute ischaemia of the cardiac muscle. The German Institute for Quality and Efficiency in Health Care (IQWiG) has now examined whether ticagrelor offers advantages to patients with acute...

2011-08-30 11:36:08

Influence long-term mortality after a heart attack? Although medication which decreases the risk of angina attacks (chest pain caused by blockage of the arteries that supply the heart), are frequently prescribed in patients who have sustained a myocardial infarction, the possible influence of medication on long-term survival is not known, with the exception of beta-blocking agents, which have been shown to decrease mortality in clinical trials performed 30 years ago. Because antianginal...

2011-07-28 17:44:30

The findings of a Montreal Heart Institute (MHI) study published in the scientific journal Cardiology suggest that ivabradine, a heart rate reduction medication, is also effective in reducing the risk of diastolic heart failure (left ventricular insufficiency) and cardiac fibrosis. The benefits of slower heart rate on mortality and morbidity associated with cardiovascular disease no longer need to be demonstrated. In this study, titled "Heart Rate Reduction by Ivabradine Reduces Diastolic...

2011-07-08 14:03:57

Study finds improvement in chest pain and exercise tolerance New research published online today in Circulation Research found that injections of adult patients' own CD34+ stem cells reduced reports of angina episodes and improved exercise tolerance time in patients with chronic, severe refractory angina (severe chest discomfort that did not respond to other therapeutic options). The phase II prospective, double-blind, randomized, controlled clinical trial was conducted at 26 centers in the...

2011-07-08 13:47:59

An injection of stem cells into the heart could offer hope to many of the 850,000 Americans whose chest pain doesn't subside even with medicine, angioplasty or surgery, according to a study in Circulation Research: Journal of the American Heart Association. Patients who received the new treatment reported half as many chest pain episodes and improved exercise capability compared to those who received a placebo. The study was the first randomized, controlled trial of stem-cell therapy to show...

2011-07-05 13:51:04

The greater the satisfaction, the greater the protection While depression and anxiety have long been recognised as risk factors for heart disease, there is less certainty over the beneficial effects of a 'positive' psychological state. Now, following a study of almost 8000 British civil servants, researchers say that a satisfying life is indeed good for the heart. The results of the study are published online today by the European Heart Journal. The civil servants - who were all members of...

2011-06-29 07:00:00

DURHAM, N.C., June 29, 2011 /PRNewswire/ -- Micell Technologies, Inc. today announced that it has completed its review of the scheduled four-month follow-up on the first 10 patients from the DESSOLVE I first-in-human trial of the MiStent Drug-Eluting Coronary Stent System ("MiStent DES"), an ultra-thin drug-eluting stent distinguished by a rapid-absorbing drug/polymer coating formulation. Based on results observed in the DESSOLVE I trial, Micell has reduced the sample size in its DESSOLVE...

2011-06-15 08:00:00

SAN DIEGO, June 15, 2011 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced that it has received clearance from the Russian Ministry of Health and Social Development to commence a Phase 3 registration study for the Company's Generx(TM) (alferminogene tadenovec, Ad5FGF-4) biologic product candidate. Generx is a new and innovative DNA-based angiogenic therapy designed for the potential treatment of myocardial ischemia due to coronary artery disease. The Russian Health...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related